Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Biotinylated anti-tenascin monoclonal antibody for use with 90-Yttrium

EU orphan designation number: EU/3/04/232   
Active ingredient: Biotinylated anti-tenascin monoclonal antibody for use with 90-Yttrium
Indication: Treatment of glioma
Sponsor: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A
Viale Shakespeare 47, 00144 Roma, Italia

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/10/2004 Centralised Orphan - Designation EMEA/OD/050/04 (2004)4198 of 20/10/2004